Japanese
close

FI (list display)

  • C12N15/00
    		•  Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (mutants or genetically engineered microorganisms C12N1/00, C12N5/00, C12N7/00; new plants A01H; plant reproduction by tissue culture techniques A01H4/00; new animals A01K67/00; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy A61K48/00; peptides in general C07K) [3, 5, 6]
    		HB CC 4B024
  • C12N15/00,100
    		•  .Dummy fI for setting up dummy fIC12N15/00 100@P [stop new assigment] HB CC 4B024
  • C12N15/00,100@P
    		•  for patent family with CPC C12N15/00 is assigned [stop new assigment] HB CC 4B024
  • C12N15/00,100@Z
    		•  Others HB CC 4B024
  • C12N15/01
    		•  .Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor [5] HB CC 4B024
  • C12N15/01@P
    		•  for patent family with CPC C12N15/01 is assigned [stop new assigment] HB CC 4B024
  • C12N15/01@Z
    		•  Others HB CC 4B024
  • C12N15/02
    		•  .Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion [5] HB CC 4B024
  • C12N15/02@P
    		•  for patent family with CPC C12N15/02 is assigned [stop new assigment] HB CC 4B024
  • C12N15/02@Z
    		•  Others HB CC 4B024
  • C12N15/03
    		•  ..Bacteria [5] HB CC 4B024
  • C12N15/03@P
    		•  for patent family with CPC C12N15/03 is assigned [stop new assigment] HB CC 4B024
  • C12N15/03@Z
    		•  Others HB CC 4B024
  • C12N15/04
    		•  ..Fungi [5] HB CC 4B024
  • C12N15/04@P
    		•  for patent family with CPC C12N15/04 is assigned [stop new assigment] HB CC 4B024
  • C12N15/04@Z
    		•  Others HB CC 4B024
  • C12N15/05
    		•  ..Plant cells [5] HB CC 4B024
  • C12N15/06
    		•  ..Animal cells [5] HB CC 4B024
  • C12N15/06,100
    		•  ...related to monoclonal antibody HB CC 4B024
  • C12N15/07
    		•  ..Human cells [5] HB CC 4B024
  • C12N15/07,100
    		•  ...related to monoclonal antibody HB CC 4B024
  • C12N15/08
    		•  ..Cells resulting from interspecies fusion [5] HB CC 4B024
  • C12N15/08,100
    		•  ...related to monoclonal antibody HB CC 4B024
  • C12N15/09
    		•  .Recombinant DNA-technology [5] HB CC 4B024
  • C12N15/09@P
    		•  for patent family with CPC C12N15/09 is assigned [stop new assigment] HB CC 4B024
  • C12N15/09@Z
    		•  Others HB CC 4B024
  • C12N15/09,100
    		•  ..Genome editing technology, e.g. using TALEN, zinc finger nuclease HB CC 4B024
  • C12N15/09,110
    		•  ...using CRIsPR/Cas HB CC 4B024
  • C12N15/09,200
    		•  ..DNA chip, microarray HB CC 4B024
  • C12N15/10
    		•  ..Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34) [5] HB CC 4B024
  • C12N15/10@P
    		•  for patent family with CPC C12N15/10, C12N15/1034, C12N15/1037, C12N15/1041, C12N15/1044, C12N15/1048, C12N15/1051, C12N15/1055, C12N15/1058, C12N15/1062, C12N15/1065, C12N15/1068, C12N15/1072, C12N15/1075, C12N15/1079, C12N15/1082, C12N15/1086, C12N15/1089, C12N15/1093, C12N15/1096 are assigned [stop new assigment] HB CC 4B024
  • C12N15/10@Z
    		•  Others HB CC 4B024
  • C12N15/10,100
    		•  ...Extraction or separation of nucleic acids from biological samples, e.g. pure separation or isolation method; conditions, buffer solutions therefore HB CC 4B024
  • C12N15/10,100@P
    		•  for patent family with CPC C12N15/1003 is assigned [stop new assigment] HB CC 4B024
  • C12N15/10,100@Z
    		•  Others HB CC 4B024
  • C12N15/10,110
    		•  ....by solid support carrier, e.g. particles, polymer HB CC 4B024
  • C12N15/10,110@P
    		•  for patent family with CPC C12N15/1006 is assigned [stop new assigment] HB CC 4B024
  • C12N15/10,110@Z
    		•  Others HB CC 4B024
  • C12N15/10,112
    		•  .....by chromatography, e.g. electrophoresis, ion-exchange, reversed-phase HB CC 4B024
  • C12N15/10,112@P
    		•  for patent family with CPC C12N15/101 is assigned [stop new assigment] HB CC 4B024
  • C12N15/10,112@Z
    		•  Others HB CC 4B024
  • C12N15/10,114
    		•  .....by using magnetic beads HB CC 4B024
  • C12N15/10,114@P
    		•  for patent family with CPC C12N15/1013 is assigned [stop new assigment] HB CC 4B024
  • C12N15/10,114@Z
    		•  Others HB CC 4B024
  • C12N15/10,120
    		•  ....by filteration, e.g. using filters, frits, membranes HB CC 4B024
  • C12N15/10,120@P
    		•  for patent family with CPC C12N15/1017 is assigned [stop new assigment] HB CC 4B024
  • C12N15/10,120@Z
    		•  Others HB CC 4B024
  • C12N15/10,200
    		•  ...Mutagenizing nucleic acids HB CC 4B024
  • C12N15/10,200@P
    		•  for patent family with CPC C12N15/102 is assigned [stop new assigment] HB CC 4B024
  • C12N15/10,200@Z
    		•  Others HB CC 4B024
  • C12N15/10,210
    		•  ....Mutagenesis using high mutagenic host mutator by inserting a genetic material, e.g. encoding an error prone polymerase, or by disrupting a gene for mismatch repair (Genome Editing Technology, C12N15/09, 100) HB CC 4B024
  • C12N15/10,210@P
    		•  for patent family with CPC C12N15/1024 is assigned [stop new assigment] HB CC 4B024
  • C12N15/10,210@Z
    		•  Others HB CC 4B024
  • C12N15/10,220
    		•  ....by DNA shuffling, e.g. RsR, sTEP, RPR HB CC 4B024
  • C12N15/10,220@P
    		•  for patent family with CPC C12N15/1027 is assigned [stop new assigment] HB CC 4B024
  • C12N15/10,220@Z
    		•  Others HB CC 4B024
  • C12N15/10,230
    		•  ....Mutagenesis by gene assembly, e.g. assembly by oligonucleotide extension PCR HB CC 4B024
  • C12N15/10,230@P
    		•  for patent family with CPC C12N15/1031 is assigned [stop new assigment] HB CC 4B024
  • C12N15/10,230@Z
    		•  Others HB CC 4B024
  • C12N15/11
    		•  ..DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology C07H21/00) [5] HB CC 4B024
  • C12N15/11@P
    		•  for patent family with CPC C12N15/11, C12N15/111 are assigned [stop new assigment] HB CC 4B024
  • C12N15/11@Z
    		•  Others HB CC 4B024
  • C12N15/113
    		•  ...Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides [2010.01] HB CC 4B024
  • C12N15/113@P
    		•  for patent family with CPC C12N15/113 is assigned [stop new assigment] HB CC 4B024
  • C12N15/113@Z
    		•  Others HB CC 4B024
  • C12N15/113,100
    		•  ....against viruses HB CC 4B024
  • C12N15/113,100@P
    		•  for patent family with CPC C12N15/1131 is assigned [stop new assigment] HB CC 4B024
  • C12N15/113,100@Z
    		•  Others HB CC 4B024
  • C12N15/113,102
    		•  .....against retroviridae, e.g. HIV HB CC 4B024
  • C12N15/113,102@P
    		•  for patent family with CPC C12N15/1132 is assigned [stop new assigment] HB CC 4B024
  • C12N15/113,102@Z
    		•  Others HB CC 4B024
  • C12N15/113,104
    		•  .....against herpetoviridae, e.g. HsV HB CC 4B024
  • C12N15/113,104@P
    		•  for patent family with CPC C12N15/1133 is assigned [stop new assigment] HB CC 4B024
  • C12N15/113,104@Z
    		•  Others HB CC 4B024
  • C12N15/113,110
    		•  ....against oncogenes or tumor suppressor genes HB CC 4B024
  • C12N15/113,110@P
    		•  for patent family with CPC C12N15/1135 is assigned [stop new assigment] HB CC 4B024
  • C12N15/113,110@Z
    		•  Others HB CC 4B024
  • C12N15/113,120
    		•  ....against growth factors, growth regulators, cytokines, lymphokines or hormones HB CC 4B024
  • C12N15/113,120@P
    		•  for patent family with CPC C12N15/1136 is assigned [stop new assigment] HB CC 4B024
  • C12N15/113,120@Z
    		•  Others HB CC 4B024
  • C12N15/113,130
    		•  ....against enzymes (virus enzymes C12N15/113, 100; receptors C12N15/113, 140) HB CC 4B024
  • C12N15/113,130@P
    		•  for patent family with CPC C12N15/1137 is assigned [stop new assigment] HB CC 4B024
  • C12N15/113,130@Z
    		•  Others HB CC 4B024
  • C12N15/113,140
    		•  ....against receptors or cell surface proteins HB CC 4B024
  • C12N15/113,140@P
    		•  for patent family with CPC C12N15/1138 is assigned [stop new assigment] HB CC 4B024
  • C12N15/113,140@Z
    		•  Others HB CC 4B024
  • C12N15/115
    		•  ...Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith [2010.01] HB CC 4B024
  • C12N15/115@P
    		•  for patent family with CPC C12N15/115 is assigned [stop new assigment] HB CC 4B024
  • C12N15/115@Z
    		•  Others HB CC 4B024
  • C12N15/117
    		•  ...Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs [2010.01] HB CC 4B024
  • C12N15/117@P
    		•  for patent family with CPC C12N15/117 is assigned [stop new assigment] HB CC 4B024
  • C12N15/117@Z
    		•  Others HB CC 4B024
  • C12N15/12
    		•  ...Genes encoding animal proteins [5] HB CC 4B024
  • C12N15/13
    		•  ....Immunoglobulins [5] HB CC 4B024
  • C12N15/14
    		•  ....Human serum albumins [5] HB CC 4B024
  • C12N15/15
    		•  ....Protease inhibitors, e.g. antithrombin, antitrypsin, hirudin [5] HB CC 4B024
  • C12N15/16
    		•  ....Hormones [5] HB CC 4B024
  • C12N15/17
    		•  .....Insulins [5] HB CC 4B024
  • C12N15/18
    		•  .....Growth hormones [5] HB CC 4B024
  • C12N15/19
    		•  ....Interferons; Lymphokines; Cytokines [5] HB CC 4B024
  • C12N15/20
    		•  .....Interferons [5] HB CC 4B024
  • C12N15/21
    		•  ......Alpha-interferons [5] HB CC 4B024
  • C12N15/22
    		•  ......Beta-interferons [5] HB CC 4B024
  • C12N15/23
    		•  ......Gamma-interferons [5] HB CC 4B024
  • C12N15/24
    		•  .....Interleukins [5] HB CC 4B024
  • C12N15/25
    		•  ......Interleukin-1 [5] HB CC 4B024
  • C12N15/26
    		•  ......Interleukin-2 [5] HB CC 4B024
  • C12N15/27
    		•  .....Colony stimulating factors [5] HB CC 4B024
  • C12N15/28
    		•  .....Tumor necrosis factors [5] HB CC 4B024
  • C12N15/29
    		•  ...Genes encoding plant proteins, e.g. thaumatin [5] HB CC 4B024
  • C12N15/30
    		•  ...Genes encoding protozoal proteins, e.g. from Plasmodium, Trypanosoma, Eimeria [5] HB CC 4B024
  • C12N15/31
    		•  ...Genes encoding microbial proteins, e.g. enterotoxins [5] HB CC 4B024
  • C12N15/32
    		•  ....Bacillus crystal proteins [5] HB CC 4B024
  • C12N15/33
    		•  ....Genes encoding viral proteins [5] HB CC 4B024
  • C12N15/34
    		•  .....Proteins from DNA viruses [5] HB CC 4B024
  • C12N15/35
    		•  ......Parvoviridae, e.g. feline panleukopenia virus, human parvovirus [5] HB CC 4B024
  • C12N15/36
    		•  ......Hepadnaviridae [5] HB CC 4B024
  • C12N15/37
    		•  ......Papovaviridae, e.g. papillomaviruses, polyomavirus, SV40 [5] HB CC 4B024
  • C12N15/38
    		•  ......Herpetoviridae, e.g. herpes simplex virus, varicella-zoster virus, Epstein-Barr virus, cytomegalovirus, pseudorabies virus [5] HB CC 4B024
  • C12N15/39
    		•  ......Poxviridae, e.g. vaccinia virus, variola virus [5] HB CC 4B024
  • C12N15/40
    		•  .....Proteins from RNA viruses, e.g. flaviviruses [5] HB CC 4B024
  • C12N15/41
    		•  ......Picornaviridae, e.g. rhinovirus, coxsackie viruses, echoviruses, enteroviruses [5] HB CC 4B024
  • C12N15/42
    		•  .......Foot-and-mouth disease virus [5] HB CC 4B024
  • C12N15/43
    		•  .......Poliovirus [5] HB CC 4B024
  • C12N15/44
    		•  ......Orthomyxoviridae, e.g. influenza virus [5] HB CC 4B024
  • C12N15/45
    		•  ......Paramyxoviridae, e.g. measles virus, mumps virus, Newcastle disease virus, canine distemper virus, rinderpest virus, respiratory syncytial viruses [5] HB CC 4B024
  • C12N15/46
    		•  ......Reoviridae, e.g. rotavirus, bluetongue virus, Colorado tick fever virus [5] HB CC 4B024
  • C12N15/47
    		•  ......Rhabdoviridae, e.g. rabies viruses, vesicular stomatitis virus [5] HB CC 4B024
  • C12N15/48
    		•  ......Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus [5] HB CC 4B024
  • C12N15/49
    		•  .......Lentiviridae, e.g. immunodeficiency viruses such as HIV, visna-maedi virus, equine infectious anaemia virus [5] HB CC 4B024
  • C12N15/50
    		•  ......Coronaviridae, e.g. infectious bronchitis virus, transmissible gastroenteritis virus [5] HB CC 4B024
  • C12N15/51
    		•  .....Hepatitis viruses [5] HB CC 4B024
  • C12N15/52
    		•  ...Genes encoding for enzymes or proenzymes [5]
    		HB CC 4B024
  • C12N15/52@P
    		•  for patent family with CPC C12N15/52 is assigned [stop new assigment] HB CC 4B024
  • C12N15/52@Z
    		•  Others HB CC 4B024
  • C12N15/53
    		•  ....Oxidoreductases (1) [5] HB CC 4B024
  • C12N15/54
    		•  ....Transferases (2) [5] HB CC 4B024
  • C12N15/55
    		•  ....Hydrolases (3) [5] HB CC 4B024
  • C12N15/56
    		•  .....acting on glycosyl compounds (3.2), e.g. amylase, galactosidase, lysozyme [5] HB CC 4B024
  • C12N15/57
    		•  .....acting on peptide bonds (3.4) [5] HB CC 4B024
  • C12N15/58
    		•  ......Plasminogen activators, e.g. urokinase, TPA [5] HB CC 4B024
  • C12N15/59
    		•  ......Chymosin [5] HB CC 4B024
  • C12N15/60
    		•  ....Lyases (4) [5] HB CC 4B024
  • C12N15/61
    		•  ....Isomerases (5) [5] HB CC 4B024
  • C12N15/62
    		•  ...DNA sequences coding for fusion proteins [5]
    		HB CC 4B024
  • C12N15/62@P
    		•  for patent family with CPC C12N15/62, C12N15/625 are assigned [stop new assigment] HB CC 4B024
  • C12N15/62@Z
    		•  Others HB CC 4B024
  • C12N15/63
    		•  ..Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression [5] HB CC 4B024
  • C12N15/63@P
    		•  for patent family with CPC C12N15/63 is assigned [stop new assigment] HB CC 4B024
  • C12N15/63@Z
    		•  Others HB CC 4B024
  • C12N15/63,100
    		•  ...Characterized by gene expression regulation via an externally inducible repressor or inducer HB CC 4B024
  • C12N15/63,100@P
    		•  for patent family with CPC C12N15/635 is assigned [stop new assigment] HB CC 4B024
  • C12N15/63,100@Z
    		•  Others HB CC 4B024
  • C12N15/64
    		•  ...General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host [5] HB CC 4B024
  • C12N15/64@P
    		•  for patent family with CPC C12N15/64 is assigned [stop new assigment] HB CC 4B024
  • C12N15/64@Z
    		•  Others HB CC 4B024
  • C12N15/65
    		•  ...using markers (enzymes used as markers C12N15/52) [5] HB CC 4B024
  • C12N15/65@P
    		•  for patent family with CPC C12N15/65 is assigned [stop new assigment] HB CC 4B024
  • C12N15/65@Z
    		•  Others HB CC 4B024
  • C12N15/66
    		•  ...General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease [5]
    		HB CC 4B024
  • C12N15/66@P
    		•  for patent family with CPC C12N15/66 is assigned [stop new assigment] HB CC 4B024
  • C12N15/66@Z
    		•  Others HB CC 4B024
  • C12N15/67
    		•  ...General methods for enhancing the expression [5] HB CC 4B024
  • C12N15/67@P
    		•  for patent family with CPC C12N15/67 is assigned [stop new assigment] HB CC 4B024
  • C12N15/67@Z
    		•  Others HB CC 4B024
  • C12N15/68
    		•  ....Stabilisation of the vector [5] HB CC 4B024
  • C12N15/68@P
    		•  for patent family with CPC C12N15/68 is assigned [stop new assigment] HB CC 4B024
  • C12N15/68@Z
    		•  Others HB CC 4B024
  • C12N15/69
    		•  ....Increasing the copy number of the vector [5] HB CC 4B024
  • C12N15/69@P
    		•  for patent family with CPC C12N15/69 is assigned [stop new assigment] HB CC 4B024
  • C12N15/69@Z
    		•  Others HB CC 4B024
  • C12N15/70
    		•  ...Vectors or expression systems specially adapted for E. coli [5]
    		HB CC 4B024
  • C12N15/70@P
    		•  for patent family with CPC C12N15/70 is assigned [stop new assigment] HB CC 4B024
  • C12N15/70@Z
    		•  Others HB CC 4B024
  • C12N15/71
    		•  ....Expression systems using regulatory sequences derived from the trp-operon [5] HB CC 4B024
  • C12N15/71@P
    		•  for patent family with CPC C12N15/71 is assigned [stop new assigment] HB CC 4B024
  • C12N15/71@Z
    		•  Others HB CC 4B024
  • C12N15/72
    		•  ....Expression systems using regulatory sequences derived from the lac-operon [5] HB CC 4B024
  • C12N15/72@P
    		•  for patent family with CPC C12N15/72 is assigned [stop new assigment] HB CC 4B024
  • C12N15/72@Z
    		•  Others HB CC 4B024
  • C12N15/73
    		•  ....Expression systems using phage lambda regulatory sequences [5] HB CC 4B024
  • C12N15/73@P
    		•  for patent family with CPC C12N15/73 is assigned [stop new assigment] HB CC 4B024
  • C12N15/73@Z
    		•  Others HB CC 4B024
  • C12N15/74
    		•  ...Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora [5]
    		HB CC 4B024
  • C12N15/74@P
    		•  for patent family with CPC C12N15/74 is assigned [stop new assigment] HB CC 4B024
  • C12N15/74@Z
    		•  Others HB CC 4B024
  • C12N15/74,100
    		•  ....for agrobacterium; rhizobium; pradisolium HB CC 4B024
  • C12N15/74,100@P
    		•  for patent family with CPC C12N15/743 is assigned [stop new assigment] HB CC 4B024
  • C12N15/74,100@Z
    		•  Others HB CC 4B024
  • C12N15/74,110
    		•  ....for lactic acid bacteria, e.g. streptococcus, lactococcus, lactobacillus, pediococcus, enterococcus, leuconostoc, propionibacterium, bifidobacterium, sporolactobacillus HB CC 4B024
  • C12N15/74,110@P
    		•  for patent family with CPC C12N15/746 is assigned [stop new assigment] HB CC 4B024
  • C12N15/74,110@Z
    		•  Others HB CC 4B024
  • C12N15/75
    		•  ....for Bacillus [5] HB CC 4B024
  • C12N15/75@P
    		•  for patent family with CPC C12N15/75 is assigned [stop new assigment] HB CC 4B024
  • C12N15/75@Z
    		•  Others HB CC 4B024
  • C12N15/76
    		•  ....for Actinomyces; for Streptomyces [5] HB CC 4B024
  • C12N15/76@P
    		•  for patent family with CPC C12N15/76 is assigned [stop new assigment] HB CC 4B024
  • C12N15/76@Z
    		•  Others HB CC 4B024
  • C12N15/77
    		•  ....for Corynebacterium; for Brevibacterium [5] HB CC 4B024
  • C12N15/77@P
    		•  for patent family with CPC C12N15/77 is assigned [stop new assigment] HB CC 4B024
  • C12N15/77@Z
    		•  Others HB CC 4B024
  • C12N15/78
    		•  ....for Pseudomonas [5] HB CC 4B024
  • C12N15/78@P
    		•  for patent family with CPC C12N15/78 is assigned [stop new assigment] HB CC 4B024
  • C12N15/78@Z
    		•  Others HB CC 4B024
  • C12N15/79
    		•  ...Vectors or expression systems specially adapted for eukaryotic hosts [5]
    		HB CC 4B024
  • C12N15/79@P
    		•  for patent family with CPC C12N15/79 is assigned [stop new assigment] HB CC 4B024
  • C12N15/79@Z
    		•  Others HB CC 4B024
  • C12N15/80
    		•  ....for fungi [5] HB CC 4B024
  • C12N15/80@P
    		•  for patent family with CPC C12N15/80 is assigned [stop new assigment] HB CC 4B024
  • C12N15/80@Z
    		•  Others HB CC 4B024
  • C12N15/81
    		•  .....for yeasts [5] HB CC 4B024
  • C12N15/81@P
    		•  for patent family with CPC C12N15/81 is assigned [stop new assigment] HB CC 4B024
  • C12N15/81@Z
    		•  Others HB CC 4B024
  • C12N15/81,100
    		•  ......for yeasts other than saccharomyces HB CC 4B024
  • C12N15/81,100@P
    		•  for patent family with CPC C12N15/815 is assigned [stop new assigment] HB CC 4B024
  • C12N15/81,100@Z
    		•  Others HB CC 4B024
  • C12N15/82
    		•  ....for plant cells [5] HB CC 4B024
  • C12N15/82@P
    		•  for patent family with CPC C12N15/82, C12N15/8201, C12N15/8202, C12N15/8206, C12N15/8207, C12N15/8209, C12N15/821, C12N15/8212, C12N15/8213, C12N15/8216, C12N15/8218, C12N15/822, C12N15/8221, C12N15/8237, C12N15/8238, C12N15/8239, C12N15/8241, C12N15/8242, C12N15/8243, C12B15/8245, C12N15/8246, C12N15/8247, C12N15/8249, C12N15/8255, C12N15/8257, C12N15/8258, C12N15/8259, C12N15/8261, C12N15/8262, C12N15/8263, C12N15/8265, C12N15/8266, C12N15/8267, C12N15/8269, C12N15/827, C12N15/8287, C12N15/8289, C12N15/829, C12N15/8291, C12N15/8293, C12N15/8294, C12N15/8295, C12N15/8297, C12N15/8298 are assigned [stop new assigment] HB CC 4B024
  • C12N15/82@Z
    		•  Others HB CC 4B024
  • C12N15/82,100
    		•  .....having characteristics in tranforming plastids, mitochondria HB CC 4B024
  • C12N15/82,100@P
    		•  for patent family with CPC C12N15/8214 is assigned [stop new assigment] HB CC 4B024
  • C12N15/82,100@Z
    		•  Others HB CC 4B024
  • C12N15/82,110
    		•  .....having characteristics in gene switch HB CC 4B024
  • C12N15/82,110@P
    		•  for patent family with CPC C12N15/8217 is assigned [stop new assigment] HB CC 4B024
  • C12N15/82,110@Z
    		•  Others HB CC 4B024
  • C12N15/82,120
    		•  .....having characteristics in Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation HB CC 4B024
  • C12N15/82,120@P
    		•  for patent family with CPC C12N15/8222 is assigned [stop new assigment] HB CC 4B024
  • C12N15/82,120@Z
    		•  Others HB CC 4B024
  • C12N15/82,122
    		•  ......having characteristics in vegetative tissue-specific promoter HB CC 4B024
  • C12N15/82,122@P
    		•  for patent family with CPC C12N15/8223, C12N15/8225, C12N15/8226, C12N15/8227, C12N15/8229 are assigned [stop new assigment] HB CC 4B024
  • C12N15/82,122@Z
    		•  Others HB CC 4B024
  • C12N15/82,124
    		•  ......having characteristics in reprodictive tissue-specific promoter HB CC 4B024
  • C12N15/82,124@P
    		•  for patent family with CPC C12N15/823, C12N15/8231, C12N15/8233 are assigned [stop new assigment] HB CC 4B024
  • C12N15/82,124@Z
    		•  Others HB CC 4B024
  • C12N15/82,126
    		•  .......seed-specific, e.g. embryo, endosperm HB CC 4B024
  • C12N15/82,126@P
    		•  for patent family with CPC C12N15/8234 is assigned [stop new assigment] HB CC 4B024
  • C12N15/82,126@Z
    		•  Others HB CC 4B024
  • C12N15/82,128
    		•  .......fruit-specific HB CC 4B024
  • C12N15/82,128@P
    		•  for patent family with CPC C12N15/8235 is assigned [stop new assigment] HB CC 4B024
  • C12N15/82,128@Z
    		•  Others HB CC 4B024
  • C12N15/82,130
    		•  .....related to pigment biosynthesis; modification of flower morphology HB CC 4B024
  • C12N15/82,130@P
    		•  for patent family with CPC C12N15/825 is assigned [stop new assigment] HB CC 4B024
  • C12N15/82,130@Z
    		•  Others HB CC 4B024
  • C12N15/82,140
    		•  .....related to amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis HB CC 4B024
  • C12N15/82,140@P
    		•  for patent family with CPC C12N15/8251, C12N15/8253, C12N15/8254 are assigned [stop new assigment] HB CC 4B024
  • C12N15/82,140@Z
    		•  Others HB CC 4B024
  • C12N15/82,150
    		•  .....for stress registance, e.g. heavy metal resistance HB CC 4B024
  • C12N15/82,150@P
    		•  for patent family with CPC C12N15/8271, C12N15/8279, C12N15/8281, C12N15/8282, C12N15/8283, C12N15/8285, C12N15/8286 are assigned [stop new assigment] HB CC 4B024
  • C12N15/82,150@Z
    		•  Others HB CC 4B024
  • C12N15/82,152
    		•  ......for drought, cold, salt resistance HB CC 4B024
  • C12N15/82,152@P
    		•  for patent family with CPC C12N15/8273 is assigned [stop new assigment] HB CC 4B024
  • C12N15/82,152@Z
    		•  Others HB CC 4B024
  • C12N15/82,154
    		•  ......for herbicide resistance HB CC 4B024
  • C12N15/82,154@P
    		•  for patent family with CPC C12N15/8274, C12N15/8275, C12N15/8277, C12N15/8278 are assigned [stop new assigment] HB CC 4B024
  • C12N15/82,154@Z
    		•  Others HB CC 4B024
  • C12N15/83
    		•  .....Viral vectors, e.g. cauliflower mosaic virus [5] HB CC 4B024
  • C12N15/83@P
    		•  for patent family with CPC C12N15/8203 is assigned [stop new assigment] HB CC 4B024
  • C12N15/83@Z
    		•  Others HB CC 4B024
  • C12N15/84
    		•  .....Ti-plasmids [5] HB CC 4B024
  • C12N15/84@P
    		•  for patent family with CPC C12N15/8205 is assigned [stop new assigment] HB CC 4B024
  • C12N15/84@Z
    		•  Others HB CC 4B024
  • C12N15/85
    		•  ....for animal cells [5] HB CC 4B024
  • C12N15/85@P
    		•  for patent family with CPC C12N15/85, C12N15/8509, C12N15/8518, C12N15/8527, C12N15/8536, C12N15/8545, C12N15/8554, C12N15/8563, C12N15/8572, C12N15/8581, C12N15/859 are assigned [stop new assigment] HB CC 4B024
  • C12N15/85@Z
    		•  Others HB CC 4B024
  • C12N15/86
    		•  .....Viral vectors [5] HB CC 4B024
  • C12N15/86@P
    		•  for patent family with CPC C12N15/86 is assigned [stop new assigment] HB CC 4B024
  • C12N15/86@Z
    		•  Others HB CC 4B024
  • C12N15/861
    		•  ......Adenoviral vectors [7] HB CC 4B024
  • C12N15/861@P
    		•  for patent family with CPC C12N15/861, C12N15/8613, C12N15/8616 are assigned [stop new assigment] HB CC 4B024
  • C12N15/861@Z
    		•  Others HB CC 4B024
  • C12N15/863
    		•  ......Poxviral vectors, e.g. vaccinia virus [7] HB CC 4B024
  • C12N15/863@P
    		•  for patent family with CPC C12N15/863, C12N15/8633, C12N15/8636 are assigned [stop new assigment] HB CC 4B024
  • C12N15/863@Z
    		•  Others HB CC 4B024
  • C12N15/864
    		•  ......Parvoviral vectors [7] HB CC 4B024
  • C12N15/864@P
    		•  for patent family with CPC C12N15/864 is assigned [stop new assigment] HB CC 4B024
  • C12N15/864@Z
    		•  Others HB CC 4B024
  • C12N15/864,100
    		•  .......Adeno-associated viral vector HB CC 4B024
  • C12N15/864,100@P
    		•  for patent family with CPC C12N15/8645 is assigned [stop new assigment] HB CC 4B024
  • C12N15/864,100@Z
    		•  Others HB CC 4B024
  • C12N15/866
    		•  ......Baculoviral vectors [7] HB CC 4B024
  • C12N15/866@P
    		•  for patent family with CPC C12N15/866 is assigned [stop new assigment] HB CC 4B024
  • C12N15/866@Z
    		•  Others HB CC 4B024
  • C12N15/867
    		•  ......Retroviral vectors [7] HB CC 4B024
  • C12N15/867@P
    		•  for patent family with CPC C12N15/867, C12N15/8673, C12N15/8676 are assigned [stop new assigment] HB CC 4B024
  • C12N15/867@Z
    		•  Others HB CC 4B024
  • C12N15/869
    		•  ......Herpesviral vectors [7] HB CC 4B024
  • C12N15/869@P
    		•  for patent family with CPC C12N15/869, C12N15/8695 are assigned [stop new assigment] HB CC 4B024
  • C12N15/869@Z
    		•  Others HB CC 4B024
  • C12N15/87
    		•  ..Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation [5] HB CC 4B024
  • C12N15/87@P
    		•  for patent family with CPC C12N15/87 is assigned [stop new assigment] HB CC 4B024
  • C12N15/87@Z
    		•  Others HB CC 4B024
  • C12N15/873
    		•  ...Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos [2010.01] HB CC 4B024
  • C12N15/873@P
    		•  for patent family with CPC C12N15/873 is assigned [stop new assigment] HB CC 4B024
  • C12N15/873@Z
    		•  Others HB CC 4B024
  • C12N15/877
    		•  ....Techniques for producing new mammalian cloned embryos [2010.01] HB CC 4B024
  • C12N15/877@P
    		•  for patent family with CPC C12N15/877, C12N15/8771, C12N15/8772, C12N15/8773, C12N15/8775, C12N15/8776, C12N15/8777, C12N15/8778 are assigned [stop new assigment] HB CC 4B024
  • C12N15/877@Z
    		•  Others HB CC 4B024
  • C12N15/88
    		•  ...using microencapsulation, e.g. using liposome vesicle [5] HB CC 4B024
  • C12N15/88@P
    		•  for patent family with CPC C12N15/88 is assigned [stop new assigment] HB CC 4B024
  • C12N15/88@Z
    		•  Others HB CC 4B024
  • C12N15/89
    		•  ...using microinjection [5] HB CC 4B024
  • C12N15/89@P
    		•  for patent family with CPC C12N15/89, C12N15/895 are assigned [stop new assigment] HB CC 4B024
  • C12N15/89@Z
    		•  Others HB CC 4B024
  • C12N15/90
    		•  ...Stable introduction of foreign DNA into chromosome [5] HB CC 4B024
  • C12N15/90@P
    		•  for patent family with CPC C12N15/90 is assigned [stop new assigment] HB CC 4B024
  • C12N15/90@Z
    		•  Others HB CC 4B024
  • C12N15/90,100
    		•  ....using homologous recombination (using genome editing technology, e.g. C12N15/09, 100 for use of TALEN, zinc finger nuclease; C12N15/09, 110 for use of CRIsPR/Cas) HB CC 4B024
  • C12N15/90,100@P
    		•  for patent family with CPC C12N15/902 is assigned [stop new assigment] HB CC 4B024
  • C12N15/90,100@Z
    		•  Others HB CC 4B024
  • C12N15/90,102
    		•  .....in yeast HB CC 4B024
  • C12N15/90,102@P
    		•  for patent family with CPC C12N15/905 is assigned [stop new assigment] HB CC 4B024
  • C12N15/90,102@Z
    		•  Others HB CC 4B024
  • C12N15/90,104
    		•  .....in mammalian cells HB CC 4B024
  • C12N15/90,104@P
    		•  for patent family with CPC C12N15/907 is assigned [stop new assigment] HB CC 4B024
  • C12N15/90,104@Z
    		•  Others HB CC 4B024
    TOP